Article
Down syndrome, RASopathies, and other rare syndromes.
Seminars in hematology - 1 Apr 2017
Kratz Christian P, Izraeli Shai
Abstract excerpt
In this article we discuss the occurrence of myeloid neoplasms in patients with a range of syndromes that are due to germline defects of the RAS signaling pathway and in patients with trisomy 21. Both RAS mutations and trisomy 21 are common somatic events contributing to leukemogenis. Thus, the increased leukemia risk observed in children affected by these conditions is biologically highly plausible. Children...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
